Journal
NATURE IMMUNOLOGY
Volume 17, Issue 3, Pages 230-240Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3384
Keywords
-
Categories
Funding
- Israeli Science Foundation Centers of Excellence
- European Research Council Framework Programme 7 [294390 PICHO]
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- I-CORE program of the Israel Science Foundation [41/11]
- Israel Cancer Research Fund
Ask authors/readers for more resources
Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors remains unclear. Whereas a minority of solid tumors are associated with overt inflammation, long-term treatment with non-steroidal anti-inflammatory drugs is remarkably effective in reducing cancer rate and death. This indicates that inflammation might have many as-yet-unrecognized facets, among which an indolent course might be far more prevalent than previously appreciated. In this Review, we explore the various inflammatory processes underlying the development and progression of colorectal cancer and discuss anti-inflammatory means for its prevention and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available